Tenecteplase biosimilar (Gennova Biopharmaceuticals)

替奈普酶生物类似药 (Gennova Biopharmaceuticals)

Report date: 2026/03/26 20:00:17

Base Information

Drug NameTenecteplase biosimilar (Gennova Biopharmaceuticals)
Drug Alias Name替奈普酶生物仿制药 (Gennova Biopharmaceuticals)VelixElaximTENECTASE
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeBiologics > Biosimilar
Mechanisms of ActionPlasminogen activators
TargetsPlasminogen
Therapy Area/IndicationsIschemic StrokeThrombosisMyocardial Infarction
Global Approved IndicationsMyocardial Infarction
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2007/01/01
Country/TerritoryUruguayIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsIschemic StrokeThrombosisMyocardial Infarction
Inactive IndicationsN/A

Other Information

ATC CodeB01AD11
Related LinksN/A